Charles River Laboratories International, Inc. Stock Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.10 EUR | -1.78% |
|
+1.76% | +14.11% |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… | |
| 07-13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
| Market Cap | 11.58B 10.16B 9.46B 8.7B 16.32B 1,106B 16.6B 112B 43.95B 549B 43.48B 42.54B 1,896B | P/E 2026 * |
39.2x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 13.39B 11.76B 10.95B 10.07B 18.87B 1,280B 19.2B 130B 50.83B 635B 50.29B 49.2B 2,193B | EV / Sales 2026 * |
3.48x | EV / Sales 2027 * | 3.31x |
| Free-Float |
97% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Charles River Laboratories International, Inc.
| 1 day | -1.78% | ||
| 1 week | +1.76% | ||
| Current month | -0.86% | ||
| 1 month | +5.46% | ||
| 3 months | +34.64% | ||
| 6 months | +6.17% | ||
| Current year | +14.11% |
| 1 week | 194.95 | 200.8 | |
| 1 month | 191.45 | 203.3 | |
| Current year | 127.95 | 203.3 | |
| 1 year | 124.25 | 203.3 | |
| 3 years | 87.7 | 251.8 | |
| 5 years | 87.7 | 388 | |
| 10 years | 59.83 | 388 |
| Manager | Title | Age | Since |
|---|---|---|---|
Birgit Girshick
CEO | Chief Executive Officer | 56 | 2026-05-04 |
Glenn Coleman
DFI | Director of Finance/CFO | 58 | 2026-04-05 |
Namandje Bumpus
CTO | Chief Tech/Sci/R&D Officer | 45 | 2026-01-11 |
| Director | Title | Age | Since |
|---|---|---|---|
James Foster
CHM | Chairman | 75 | 1999-12-31 |
Birgit Girshick
BRD | Director/Board Member | 56 | 2026-05-04 |
Martin MacKay
CHM | Chairman | 69 | 2026-05-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.78% | +1.76% | - | - | 10.8B | ||
| +0.14% | -0.67% | -0.88% | +11.02% | 47.74B | ||
| -2.24% | +0.31% | +393.45% | +615.13% | 39.98B | ||
| +1.40% | +3.69% | +12.21% | +46.79% | 36.23B | ||
| +13.94% | +20.49% | +22.85% | +7.42% | 35.59B | ||
| -0.73% | +3.38% | +4.94% | +41.45% | 27.91B | ||
| +0.40% | -0.30% | - | - | 16.71B | ||
| -3.12% | +7.39% | +26.03% | +124.08% | 16.45B | ||
| +2.39% | -1.64% | +4.74% | +9.95% | 13.21B | ||
| +6.79% | +8.17% | -4.97% | -28.52% | 12.93B | ||
| Average | +1.72% | +2.97% | +57.30% | +103.42% | 27.42B | |
| Weighted average by Cap. | +1.94% | +2.54% | +76.11% | +130.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.85B 3.38B 3.14B 2.89B 5.42B 368B 5.52B 37.31B 14.6B 182B 14.45B 14.14B 630B | 3.92B 3.44B 3.21B 2.95B 5.53B 375B 5.62B 38.04B 14.89B 186B 14.73B 14.41B 642B |
| Net income | 285M 250M 233M 214M 402M 27.24B 409M 2.76B 1.08B 13.51B 1.07B 1.05B 46.67B | 417M 366M 341M 314M 588M 39.87B 598M 4.05B 1.58B 19.77B 1.57B 1.53B 68.31B |
| Net Debt | 1.81B 1.59B 1.48B 1.36B 2.56B 173B 2.6B 17.58B 6.88B 85.92B 6.81B 6.66B 297B | 1.39B 1.22B 1.13B 1.04B 1.95B 132B 1.99B 13.43B 5.26B 65.63B 5.2B 5.09B 227B |
| Date | Price | Change |
|---|---|---|
| 26-07-28 | €196.10 | -1.78% |
| 26-07-27 | €199.65 | -0.57% |
| 26-07-24 | €200.80 | +3.00% |
| 26-07-23 | €194.95 | +1.83% |
| 26-07-22 | €191.45 | -0.65% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
Select your edition
All financial news and data tailored to specific country editions

















